Engage Therapeutics

Please note: The information displayed on this page might be outdated.
Engage Therapeutics: Engage Therapeutics is focused on bringing patients with epilepsy suffering from uncontrolled seizures what could be the first rescue treatment with the potential to stop their seizures.

Epilepsy affects at least three million people in the United States. One in three of those people have what is considered refractory epilepsy with uncontrolled seizures, as one or more anti-epileptic drugs has not worked for them. Approximately twenty percent or 200,000 of these patients have a predictive pattern of seizures, and Engage Therapeutics is working to bring these patients Staccato alprazolam, which is designed to stop a seizure in patients who have a predictable seizure pattern.
Based in...
US - Middle Atlantic
Disease Space
Central Nervous System
Therapeutic Modalities
Drug Delivery
31 Lenox Road
Summit, NJ 07901
United States

Company Participants at Solebury Trout Corporate Access 1x1 Calls - Week of April 13

  • Greg Mayes, CEO